நித்யா பாலசுப்ரமணியன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நித்யா பாலசுப்ரமணியன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நித்யா பாலசுப்ரமணியன் Today - Breaking & Trending Today

Pharma stocks to buy: Nithya Balasubramanian's top 3 pharma stock picks

Sun Pharma,
Cipla and Gland Pharma are the three largecap pharma stocks on which Nithya Balasubramanian of Sanford Bernstein is bullish on. Edited excerpts from an interview:
What are your top picks in the pharma pack? Which stocks do you think can get rerated?
We cover mostly largecap names. Our top picks right now are Sun Pharma, Cipla and Gland Pharma. The valuations are slightly at an elevated level, but we believe that there is a possibility of continued growth and momentum in earnings. This will be appreciated by the market as well.
Sun Pharma s potential in the specialty business is undervalued. ....

Sun Pharma , Nithya Balasubramanian , Sanford Bernstein , Gland Pharma , சூரியன் பார்மா , நித்யா பாலசுப்ரமணியன் , சான்ஃபோர்ட் பெர்ன்ஸ்டீன் , சுரப்பி பார்மா ,

Pharma stocks to buy: 6 pharma stocks to bet on amid Covid 2.0

Nithya Balasubramanian, Director, Sanford Bernstein, says stocks like Cipla, Zydus Cadila, Biocon, Glenmark, Dr Reddy’s and Gland Pharma are among those that are likely to benefit in the pandemic. Edited excerpts from an interview:
Which end of the Indian pharma space you are excited about both in terms of growth and margin sustainability? APIs, vaccine makers or biosimilars?
Biosimilars is very exciting in terms of opportunity. Around $60 billion worth of biologics are going off patent which is a significant opportunity. Unfortunately, most companies in India have not invested in addressing the first wave of opportunity. Other than Biocon, there is barely anyone with a significant portfolio of biosimilars. Lupin has a few of them while Aurobindo and Dr Reddy s Lab are working on it. All of them are likely to be late in the market in the first wave. Biosimilars does not seem to be a meaningful opportunity for most large cap companies today in the near to mid term. ....

Zydus Cadila , Nithya Balasubramanian , Sanford Bernstein , Dr Reddy Lab , Gland Pharma , ஜய்துச் காடிலா , நித்யா பாலசுப்ரமணியன் , சான்ஃபோர்ட் பெர்ன்ஸ்டீன் , டாக்டர் சிவப்பு ஆய்வகம் , சுரப்பி பார்மா ,

Just how scary is the COVID outbreak in India right now?

(Kiyoshi Ota/Pool Photo via AP)
I have no deep thoughts about this subject but I want to put it on your radar because there’s every indication that it’ll end up as the worst COVID outbreak on Earth since the pandemic began. That distinction currently belongs to Brazil, I think, but India’s population dwarfs that country’s. And India is poorer per capita, which means more people in dire need of hospital care may not be able to get it.
Where the death toll might go on this, God only knows.
The epidemic curve there has turned vertical. And it must be stressed: In a poor nation that isn’t doing much testing (India ranks 116th in tests per capita), the number of confirmed cases only scratches the surface of the true number of infections. ....

Narendra Modi , Scott Gottlieb , Nithya Balasubramanian , Williama Haseltine , Eric Topol Erictopol , Ashishk Jha , University Of Washington , Harvard Medical School , Financial Times , Eric Topol , Kumbh Mela , Ganges River , Jesse Bloom , Bernstein India , நரேந்திர மோடி , ஸ்காட் காட்‌லீப் , நித்யா பாலசுப்ரமணியன் , பல்கலைக்கழகம் ஆஃப் வாஷிங்டன் , ஹார்வர்ட் மருத்துவ பள்ளி , நிதி முறை , எரிக் தோப்போல் , கும்பம் மேளா , கும்பல்கள் நதி , ஜெஸ்ஸி பூக்கும் ,

India's Double Mutation Jumps To 10 Countries. All You Need To Know

India s Double Mutant Jumps To 10 Countries. All You Need To Know
India s Double Mutant Jumps To 10 Countries. All You Need To Know
The new variant, which has a so-called double mutation, is thought to be fueling India s deadlier new wave of cases that has made it the world s second worst-hit country, surpassing Brazil again, and has already begun to overwhelm its hospitals and crematoriums.
A health worker takes a swab sample under mobile phone torchlight during a power cut.
With India s daily tally of Covid-19 infections surging by records, public health experts worry that a new possibly more virulent coronavirus variant could be racing through the crowded nation of more than 1.3 billion people. ....

Andhra Pradesh , New Zealand , United Kingdom , South Africa , Maria Van Kerkhove , Anurag Agrawal , Rakesh Mishra , Eric Feigl , Nithya Balasubramanian , Aparna Mukherjee , Williama Haseltine , Van Kerkhove , University Of Washington , Council Of Scientific , Centre For Cellular , World Health Organization , Harvard Medical School , Indian Council Of Medical Research , Industrial Research , All You Need To Know , Indian Council , Medical Research , Jesse Bloom , Bernstein India , Under Investigation , Eric Feigl Ding ,

There's a new COVID-19 variant in India. How worried should we be?

Apr 19, 2021
With India’s daily tally of COVID-19 infections surging by records, public health experts worry that a new possibly more virulent coronavirus variant could be racing through the crowded nation of more than 1.3 billion people.
The new variant, which has a so-called double mutation, is thought to be fueling India’s deadlier new wave of cases that has made it the world’s second worst-hit country, surpassing Brazil again, and has already begun to overwhelm its hospitals and crematoriums. India has reported more than 14.5 million COVID-19 cases so far and more than 175,600 fatalities.
“This is a variant of interest we are following,” Maria Van Kerkhove, the World Health Organization’s technical lead officer on COVID-19, told reporters Friday. “Having two of these mutations, which have been seen in other variants around the world, are concerning,” she said, adding that there was a similarity with mutations that increase transmission ....

Andhra Pradesh , New Zealand , United Kingdom , South Africa , Rakesh Mishra , Maria Van Kerkhove , Aparna Mukherjee , Nithya Balasubramanian , Williama Haseltine , Van Kerkhove , Anurag Agrawal , University Of Washington , Council Of Scientific , World Health Organization , Harvard Medical School , Indian Council Of Medical Research , Industrial Research , With India , Indian Council , Medical Research , Jesse Bloom , Bernstein India , Molecular Biology , Under Investigation , Japan Times , Covid 19 ,